Registry of Lobbyists

Registration - In-house Organization

BIOTECANADA / ANDREW CASEY, President & CEO

Registration Information

In-house Organization name: BIOTECANADA
Responsible Officer Name: ANDREW CASEY, President & CEO 
Responsible Officer Change History
Initial registration start date: 2005-04-05
Registration status: Active
Registration Number: 836594-354

Associated Communications

Total Number of Communication Reports: 336

Monthly communication reports in the last 6 months: 7

Version 1 of 35 (2005-04-05 to 2005-09-26)

Version 1 of 35 (2005-04-05 to 2005-09-26) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Organization Information

Organization: BIOTECANADA
420 - 130 ALBERT STREET
OTTAWA, ON  K1P 5G4
Canada
Telephone number: 613-230-5585  Ext.: 229
Fax number: 613-563-8850  
Responsible officer name and position during the period of this registration: PETER BRENDERS, PRESIDENT & CEO  
 
Description of the organization's activities: BIOTECANADA IS A NOT-FOR-PROFIT ORGANIZATION THAT IS THE VOICE FOR BIOTECHNOLOGY IN CANADA, FOSTERING THE GROWTH, PROFITABILITY, AND LONG-TERM VIABILITY OF THE CANADIAN BIOTECHNOLOGY INDUSTRY. BIOTECANADA FOCUSES ON THE ISSUES AND ACTIVITIES AFFECTING THE CANADIAN BIOTECHNOLOGY COMMUNITY, BOTH NATIONALLY AND INTERNATIONALLY. BIOTECANADA IS INVOLVED IN MANY INITIATIVES TO ADDRESS THESE ISSUES, INCLUDING REGULATORY AND POLICY ADVOCACY, FINANCE, AND THE COLLECTION AND DISSEMINATION OF MARKET INFORMATION. BIOTECANADA, IN PARTNERSHIP WITH THE REGIONAL BIOTECHNOLOGY ASSOCIATIONS, REPRESENTS 85 PERCENT OF THE CANADIAN BIOTECHNOLOGY COMMUNITY
Organization's membership or classes of membership: BIOTECANADA CURRENTLY HAS OVER 170 MEMBERS. THE MEMBERSHIP IS COMPRISED OF COMPANIES IN THE HUMAN HEALTH CARE, AGRICULTURAL, ENVIRONMENTAL AND SERVICE SECTORS AS WELL AS ASSOCIATIONS AND UNIVERSITIES. THE MEMBERSHIP CATEGORIES ARE: 1. BIOTECHNOLOGY INDUSTRY: FIRMS, CORPORATIONS OR SUBSIDIARIES, DIVISIONS OR UNITS THEREOF WHICH COMMERCIALIZE BIOTECHNOLOGY-DERIVED PRODUCTS AND/OR ARE ACTIVE IN BIOTECHNOLOGY RELATED R&D. 2. SERVICE INDUSTRY: FIRMS, CORPORATIONS OR SUBSIDIARIES, DIVISIONS OR UNITS THEREOF WHICH ARE CHARTERED BANKS OR THEIR SUBSIDIARIES; PROVIDE FINANCIAL, LEGAL, INSURANCE, CONSULTING OR OTHER SERVICES; OR PROVIDE SUPPLIES OR EQUIPMENT. 3. NOT-FOR-PROFIT: REGIONAL/SECTORAL ASSOCIATIONS, ACADEMIC ORGANIZATIONS AND PROFESSIONAL ASSOCIATIONS, GOVERNMENT DEPARTMENTS AND AGENCIES WITH A SCIENCE AND TECHNOLOGY MANDATE, OR FOREIGN ORGANIZATIONS
 
Was the organization funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No
 

B. Lobbyists Employed by the Organization

Name: CATE MCCREADY
Position title: VP, EXTERNAL AFFAIRS
Public offices held: Unknown
 
Name: Philip Schwab
Position title: VP, Policy & Sector Affairs
Public offices held: Unknown
 

C. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Agriculture and Agri-Food Canada (AAFC), Canadian International Development Agency (CIDA), CDN FOOD INSPECTION AGENCY, CIHR, Environment Canada, Finance Canada (FIN), Fisheries and Oceans Canada (DFO), Foreign Affairs and International Trade Canada (DFAITC), GENOME CANADA, Health Canada (HC), Human Resources Development Canada (HRDC), Industry Canada, National Research Council (NRC), Natural Resources Canada (NRCan), Natural Sciences and Engineering Research Council (NSERC), Office of the Information and Privacy Commissioner (OIPC), Patented Medicine Prices Review Board (PMPRB), Privy Council Office (PCO), Procurement Review Board of Canada (PRB), Public Works and Government Services Canada, Revenue Canada (RC), Social Sciences and Humanities Research Council (SSHRC), Statistics Canada (StatCan), Treasury Board Of Canada Secretariat (TBS)
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format
 
Subject Matter: Areas of Concern: Agriculture, BIOTECHNOLOGY, Consumer Issues, Employment and Training, Energy, Environment, Fisheries, Forestry, Government Procurement, Health, Immigration, Industry, Intellectual Property, International Relations, International Trade, Science and Technology, Small Business, Taxation and Finance
 
Subject Matter: Retrospective: CANADIAN BIOTECHNOLOGY STRATEGY; BIOSAFETY PROTOCOL; INTELLECTUAL PROPERTY POLICY FOR BIOTECHNOLOGY; PATENTS: HIGHER LIFE FORMS, PATENT TERM RESTORATION; PATENTED MEDICINE PRICES REVIEW BOARD (PMPRB) PRICE REVIEW ISSUES; REVIEW OF THERAPEUTIC PRODUCTS PROGRAM (TPP) COST RECOVERY REVIEW; WORLD TRADE ORGANIZATION (WTO) ISSUES: TRIPS AGREEMENT, DISPUTE RESOLUTION; CANADIAN ENVIRONMENT PROTECTION ACT AND REGULATIONS; FOOD AND DRUGS ACT AND REGULATIONS; SUBMISSION REVIEW PROCESS FOR BIOLOGICS; FOOD LABELLING; SCIENTIFIC RESEARCH & EXPERIMENTAL DEVELOPMENT (SR&ED) TAX CREDIT PROGRAM
Subject Matter: Prospective: NATIONAL BIOTECH WEEK; BIOTECH AWARENESS (CAUCUS) EFFORTS OF PARLIAMENTARIANS; IMPROVED TAXATION FRAMEWORK; SMART REGULATIONS / REGULATORY IMPROVEMENTS; ORPHAN PRODUCT POLICIES; CANADIAN BIOTECHNOLOGY STRATEGY / INNOVATION AGENDA; INTELLECTUAL PROPERTY/PATENT POLICY AND REGULATIONS; TECHNOLOGY PARTNERSHIPS CANADA (TPC); PMPRB PRICE REVIEW ISSUES; WTO ISSUES: TRIPS AGREEMENT, DISPUTE RESOLUTION; CANADIAN ENVIRONMENTAL PROTECTION ACT AND REGULATIONS; HEALTH CANADA: FOOD AND DRUGS ACT AND REGULATIONS, SUBMISSION REVIEW PROCESS FOR BIOLOGICS, COST RECOVERY REVIEW, REPRODUCTIVE AND GENETIC TECHNOLOGIES; NOVEL FOODS AND FOOD LABELLING; REGULATORY APPROVAL PROCESS FOR PLANTS WITH NOVEL TRAITS; SR&ED TAX CREDIT PROGRAM; BIOSAFETY PROTOCOL
 

Details Regarding the Identified Subject Matter

Categories Description
Regulation FOOD AND DRUGS ACT AND REGULATIONS
Policy or Program Support for capital formation including tax law recognition of Limited Liability Corporations (LLCs), improvements to TPC and SR&ED; Creation of a modern regulatory environment including removal of review backlogs at Health Canada, recognition of international standards and reviews, and establishing 10 years data protection for intellectual property




Date Modified: